Central Venous Catheter Market By Product type (Tunneled Catheters, Non-Tunneled Catheters), By Property (Antimicrobial Catheters, Non-Antimicrobial Catheters), By Design (Single Lumen, Double Lumen, Multiple Lumen), By End-User (Hospital, Cancer treatment centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Central Venous Catheter Market

The Central venous catheter Market is likely to experience a significant growth rate of 6.4% from 2022-2032 owing to increasing market demand for antiemetic drugs –

 

Central venous catheters are defined as an indwelling device inserted into a large, central vein such as internal jugular, subclavian, or femoral. Central venous catheters are used for blood transfusion and infusion of chemotherapy drugs. These catheters are available with various numbers of lumens such as single lumen, dual lumen and multi-lumens.

The key market trends driving the growth of the central venous catheter market include rise in demand for central venous catheter for treatment of accidental injury, improvements in healthcare infrastructure, and investments in R&D activities by key market players. In addition, rise in prevalence of chronic diseases such as cancer and diabetes contributes to the growth of the market. For instance, according to American Cancer Society (ACS) states that, a total of 1.9 million new cancer cases and 609,360 deaths from cancer are expected to occur in the U.S. in 2022, and cancer death rate for men and women combined has decreased to 32% from its peak in 1991 to 2019. The central venous catheters are used for the treatment of critically ill patients suffer with chronic diseases. Thus, high prevalence of chronic disease along with growing demand of central venous catheters is expected to drive the central venous catheter market during the forecast period.

In addition, a rise in awareness about the effectiveness of central venous catheter, surge in incidence of cardiovascular diseases, increase in availability & affordability of healthcare treatment and rise in number of hospital admission contributes to the growth of market. According to Centers for Disease Control and Prevention (CDC), Coronary heart disease is the most common type of heart disease, killing 375,476 people in 2021. However, the concern related to infections associated with central venous catheter and the product recall by manufacturers are expected to restrict the market growth. Conversely, increased adoption of central venous catheter among the population is expected to provide lucrative opportunities for the growth of the market. On the contrary, rise in research and development activities by key market players and increase in healthcare expenditure has further encouraged many key players to enter emerging markets, thus offering lucrative opportunities for the expansion of the central venous catheter market.

The market also offers growth opportunities to the key players in the market. The target population is in tremendous need of cost-effective services in regions like Europe and Asia-Pacific. Hence, challenges to cater the unmet needs of the target population provide growth opportunities. Online medical services have gained high traction in the last 4 years. As a result, engaged stakeholders in the industry have partnered with existing delivery services organizations.

The central venous catheter market is segmented into product type, property, design, end user, and region. On the basis of product type, the market is bifurcated into tunneled catheters and non-tunneled catheters. On the basis of property, the market is bifurcated into antimicrobial catheters and non-antimicrobial catheters. On the basis of design, the market is classified into single lumen, double lumen and multiple lumens. On the basis of end user, it is classified into hospitals, cancer treatment centers, and others. Region-wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The key players profiled in the AngioDynamics, Asahi Kasei Corporation., B. Braun, Becton Dickinson and Company, ICU Medical, Medtronic plc., Merit medical, Rex Medical, Teleflex Incorporated and Vygon Ltd. The players in the market have been actively engaged in the adoption of various strategies such as acquisition, product launch, and partnership to remain competitive and gain an advantage over the competitors in the market

                                                                                                                                        

Key Market Insights (Updated)

On the basis of product type, the non-tunneled catheters segment was the major share contributor in 2022.

By property, the non-antimicrobial catheters segment dominated the market in 2022, and the speech therapy segment is expected to grow at the fastest CAGR during the forecast period.

On the basis of design, the double lumen segment is anticipated to grow with the highest CAGR throughout the forecast period.

By end user, the hospital segment held the highest position in terms of revenue in 2022, whereas homecare are expected to grow at the highest CAGR during the forecast period.

Region wise, North America garnered the largest revenue share in 2022, however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

 

Overview

The central venous catheter market was valued at $2,571.23 million in 2022 and is estimated to reach $4,730.10 million by 2032, exhibiting a CAGR of 6.4% from 2023 to 2032.

Central venous catheters are defined as an indwelling device inserted into a large, central vein such as internal jugular, subclavian, or femoral. Central venous catheters are used for blood transfusion and infusion of chemotherapy drugs. These catheters are available with various numbers of lumens.

The growth of the central venous catheter market is driven by surge in incidence of cardiovascular diseases, increase in availability & affordability of healthcare treatment and rise in number of hospital admission. The increase in incidence of acute kidney injury and kidney failure drives the demand for central venous catheters. These catheters are used for hemodialysis. For instance, according to American Kidney Fund, in 2020, more than 562,000 Americans were on dialysis. Growth in a number of hemodialysis thus consequently drives the market growth.

Moreover, large medical technology firms have increasingly focused on acquiring companies that provide solutions for central venous catheters, which is expected to notably contribute toward the market growth. Prominent players in the global central venous catheter market have adopted various strategies such as product launches, acquisitions, and investments in R&D for advancement in central venous catheters to strengthen their position in the market and sustain the competitive environment. For instance, in January 2021, Shenzhen Prunus Technology Co., Ltd., acquired the critical care products division of Biosensors International Group, Ltd, officially entering the field of critical care consumables business. The acquired products of the subsidiary include central venous catheters, pressure transducers, pulmonary artery catheters, pacing catheters, thrombolysis catheters, urinary catheters, and other medical consumables.

Moreover, alarming increase in prevalence of kidney diseases, technological advancements in central venous catheter, and rise in the number of accidents and trauma are some of the key factors that drive the growth of the market. Furthermore, rise in geriatric population and changes in lifestyles notably contribute toward the growth in prevalence of diseases. However, concern related to catheter infections and product recalls by manufacturers is expected to hamper the market growth. Conversely, increased application of central venous catheter among the geriatric population and emergency health conditions is expected to provide lucrative opportunities for the growth of the market in the near future. In addition, extensive R&D activities in the field of central venous catheter along with significant improvement in medical infrastructure are anticipated to open new avenues for the expansion of the market during the forecast period.

The central venous catheter market is segmented into product type, property, design, end user, and region. On the basis of product type, the market is bifurcated into tunneled catheters and non-tunneled catheters. On the basis of property, the market is bifurcated into antimicrobial catheters and non-antimicrobial catheters. On the basis of design, the market is classified into single lumen, double lumen and multiple lumens. On the basis of end user, it is classified into hospitals, cancer treatment centers, and others. On the basis of region, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major companies profiled in the report include AngioDynamics, Asahi Kasei Corporation., B. Braun, Becton Dickinson and Company, ICU Medical, Medtronic plc., Merit medical, Rex Medical, Teleflex Incorporated and Vygon Ltd.

Key Benefits For Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the central venous catheter market analysis from 2022 to 2032 to identify the prevailing central venous catheter market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the central venous catheter market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global central venous catheter market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

● Quarterly Update and* (only available with a corporate license, on listed price)

● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.

● Free Upcoming Version on the Purchase of Five and Enterprise User License.

● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)

● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)

● Free data Pack on the Five and Enterprise User License. (Excel version of the report)

● Free Updated report if the report is 6-12 months old or older.

● 24-hour priority response*

● Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline talk to the sales executive to know more)

○ Teleflex Incorporate

Scope of Central Venous Catheter Market Report

1.1. Report description

1.2. Key market segments

1.3. Key benefits to the stakeholders

1.4. Research Methodology

1.4.1. Primary research

1.4.2. Secondary research

1.4.3. Analyst tools and models

2.1. CXO Perspective

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top impacting factors

3.2.2. Top investment pockets

3.3. Porter’s five forces analysis

3.3.1. Moderate bargaining power of suppliers

3.3.2. Moderate threat of new entrants

3.3.3. Moderate threat of substitutes

3.3.4. Moderate intensity of rivalry

3.3.5. Moderate bargaining power of buyers

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Rise in prevalence of chronic diseases

3.4.1.2. Increase in healthcare expenditure and improvements in healthcare facilities

3.4.1.3. Upsurge in geriatric population

3.4.2. Restraints

3.4.2.1. 3.4.2.1. Product recall by manufacturers

3.4.3. Opportunities

3.4.3.1. High growth potential in developing economies

3.5. COVID-19 Impact Analysis on the market

4.1. Overview

4.1.1. Market size and forecast

4.2. Tunneled Catheters

4.2.1. Key market trends, growth factors and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market share analysis by country

4.3. Non-Tunneled Catheters

4.3.1. Key market trends, growth factors and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market share analysis by country

5.1. Overview

5.1.1. Market size and forecast

5.2. Antimicrobial Catheters

5.2.1. Key market trends, growth factors and opportunities

5.2.2. Market size and forecast, by region

5.2.3. Market share analysis by country

5.3. Non-Antimicrobial Catheters

5.3.1. Key market trends, growth factors and opportunities

5.3.2. Market size and forecast, by region

5.3.3. Market share analysis by country

6.1. Overview

6.1.1. Market size and forecast

6.2. Single Lumen

6.2.1. Key market trends, growth factors and opportunities

6.2.2. Market size and forecast, by region

6.2.3. Market share analysis by country

6.3. Double Lumen

6.3.1. Key market trends, growth factors and opportunities

6.3.2. Market size and forecast, by region

6.3.3. Market share analysis by country

6.4. Multiple Lumen

6.4.1. Key market trends, growth factors and opportunities

6.4.2. Market size and forecast, by region

6.4.3. Market share analysis by country

7.1. Overview

7.1.1. Market size and forecast

7.2. Hospital

7.2.1. Key market trends, growth factors and opportunities

7.2.2. Market size and forecast, by region

7.2.3. Market share analysis by country

7.3. Cancer treatment centers

7.3.1. Key market trends, growth factors and opportunities

7.3.2. Market size and forecast, by region

7.3.3. Market share analysis by country

7.4. Others

7.4.1. Key market trends, growth factors and opportunities

7.4.2. Market size and forecast, by region

7.4.3. Market share analysis by country

8.1. Overview

8.1.1. Market size and forecast By Region

8.2. North America

8.2.1. Key trends and opportunities

8.2.2. Market size and forecast, by Product type

8.2.3. Market size and forecast, by Property

8.2.4. Market size and forecast, by Design

8.2.5. Market size and forecast, by End-User

8.2.6. Market size and forecast, by country

8.2.6.1. U.S.

8.2.6.1.1. Key market trends, growth factors and opportunities

8.2.6.1.2. Market size and forecast, by Product type

8.2.6.1.3. Market size and forecast, by Property

8.2.6.1.4. Market size and forecast, by Design

8.2.6.1.5. Market size and forecast, by End-User

8.2.6.2. Canada

8.2.6.2.1. Key market trends, growth factors and opportunities

8.2.6.2.2. Market size and forecast, by Product type

8.2.6.2.3. Market size and forecast, by Property

8.2.6.2.4. Market size and forecast, by Design

8.2.6.2.5. Market size and forecast, by End-User

8.2.6.3. Mexico

8.2.6.3.1. Key market trends, growth factors and opportunities

8.2.6.3.2. Market size and forecast, by Product type

8.2.6.3.3. Market size and forecast, by Property

8.2.6.3.4. Market size and forecast, by Design

8.2.6.3.5. Market size and forecast, by End-User

8.3. Europe

8.3.1. Key trends and opportunities

8.3.2. Market size and forecast, by Product type

8.3.3. Market size and forecast, by Property

8.3.4. Market size and forecast, by Design

8.3.5. Market size and forecast, by End-User

8.3.6. Market size and forecast, by country

8.3.6.1. Germany

8.3.6.1.1. Key market trends, growth factors and opportunities

8.3.6.1.2. Market size and forecast, by Product type

8.3.6.1.3. Market size and forecast, by Property

8.3.6.1.4. Market size and forecast, by Design

8.3.6.1.5. Market size and forecast, by End-User

8.3.6.2. France

8.3.6.2.1. Key market trends, growth factors and opportunities

8.3.6.2.2. Market size and forecast, by Product type

8.3.6.2.3. Market size and forecast, by Property

8.3.6.2.4. Market size and forecast, by Design

8.3.6.2.5. Market size and forecast, by End-User

8.3.6.3. UK

8.3.6.3.1. Key market trends, growth factors and opportunities

8.3.6.3.2. Market size and forecast, by Product type

8.3.6.3.3. Market size and forecast, by Property

8.3.6.3.4. Market size and forecast, by Design

8.3.6.3.5. Market size and forecast, by End-User

8.3.6.4. Italy

8.3.6.4.1. Key market trends, growth factors and opportunities

8.3.6.4.2. Market size and forecast, by Product type

8.3.6.4.3. Market size and forecast, by Property

8.3.6.4.4. Market size and forecast, by Design

8.3.6.4.5. Market size and forecast, by End-User

8.3.6.5. Spain

8.3.6.5.1. Key market trends, growth factors and opportunities

8.3.6.5.2. Market size and forecast, by Product type

8.3.6.5.3. Market size and forecast, by Property

8.3.6.5.4. Market size and forecast, by Design

8.3.6.5.5. Market size and forecast, by End-User

8.3.6.6. Rest of Europe

8.3.6.6.1. Key market trends, growth factors and opportunities

8.3.6.6.2. Market size and forecast, by Product type

8.3.6.6.3. Market size and forecast, by Property

8.3.6.6.4. Market size and forecast, by Design

8.3.6.6.5. Market size and forecast, by End-User

8.4. Asia-Pacific

8.4.1. Key trends and opportunities

8.4.2. Market size and forecast, by Product type

8.4.3. Market size and forecast, by Property

8.4.4. Market size and forecast, by Design

8.4.5. Market size and forecast, by End-User

8.4.6. Market size and forecast, by country

8.4.6.1. China

8.4.6.1.1. Key market trends, growth factors and opportunities

8.4.6.1.2. Market size and forecast, by Product type

8.4.6.1.3. Market size and forecast, by Property

8.4.6.1.4. Market size and forecast, by Design

8.4.6.1.5. Market size and forecast, by End-User

8.4.6.2. Japan

8.4.6.2.1. Key market trends, growth factors and opportunities

8.4.6.2.2. Market size and forecast, by Product type

8.4.6.2.3. Market size and forecast, by Property

8.4.6.2.4. Market size and forecast, by Design

8.4.6.2.5. Market size and forecast, by End-User

8.4.6.3. India

8.4.6.3.1. Key market trends, growth factors and opportunities

8.4.6.3.2. Market size and forecast, by Product type

8.4.6.3.3. Market size and forecast, by Property

8.4.6.3.4. Market size and forecast, by Design

8.4.6.3.5. Market size and forecast, by End-User

8.4.6.4. Australia

8.4.6.4.1. Key market trends, growth factors and opportunities

8.4.6.4.2. Market size and forecast, by Product type

8.4.6.4.3. Market size and forecast, by Property

8.4.6.4.4. Market size and forecast, by Design

8.4.6.4.5. Market size and forecast, by End-User

8.4.6.5. South Korea

8.4.6.5.1. Key market trends, growth factors and opportunities

8.4.6.5.2. Market size and forecast, by Product type

8.4.6.5.3. Market size and forecast, by Property

8.4.6.5.4. Market size and forecast, by Design

8.4.6.5.5. Market size and forecast, by End-User

8.4.6.6. Rest of Asia-Pacific

8.4.6.6.1. Key market trends, growth factors and opportunities

8.4.6.6.2. Market size and forecast, by Product type

8.4.6.6.3. Market size and forecast, by Property

8.4.6.6.4. Market size and forecast, by Design

8.4.6.6.5. Market size and forecast, by End-User

8.5. LAMEA

8.5.1. Key trends and opportunities

8.5.2. Market size and forecast, by Product type

8.5.3. Market size and forecast, by Property

8.5.4. Market size and forecast, by Design

8.5.5. Market size and forecast, by End-User

8.5.6. Market size and forecast, by country

8.5.6.1. Brazil

8.5.6.1.1. Key market trends, growth factors and opportunities

8.5.6.1.2. Market size and forecast, by Product type

8.5.6.1.3. Market size and forecast, by Property

8.5.6.1.4. Market size and forecast, by Design

8.5.6.1.5. Market size and forecast, by End-User

8.5.6.2. Saudi Arabia

8.5.6.2.1. Key market trends, growth factors and opportunities

8.5.6.2.2. Market size and forecast, by Product type

8.5.6.2.3. Market size and forecast, by Property

8.5.6.2.4. Market size and forecast, by Design

8.5.6.2.5. Market size and forecast, by End-User

8.5.6.3. South Africa

8.5.6.3.1. Key market trends, growth factors and opportunities

8.5.6.3.2. Market size and forecast, by Product type

8.5.6.3.3. Market size and forecast, by Property

8.5.6.3.4. Market size and forecast, by Design

8.5.6.3.5. Market size and forecast, by End-User

8.5.6.4. Rest of LAMEA

8.5.6.4.1. Key market trends, growth factors and opportunities

8.5.6.4.2. Market size and forecast, by Product type

8.5.6.4.3. Market size and forecast, by Property

8.5.6.4.4. Market size and forecast, by Design

8.5.6.4.5. Market size and forecast, by End-User

9.1. Introduction

9.2. Top winning strategies

9.3. Product Mapping of Top 10 Player

9.4. Competitive Dashboard

9.5. Competitive Heatmap

9.6. Top player positioning, 2022

10.1. Asahi Kasei Corporation.

10.1.1. Company overview

10.1.2. Key Executives

10.1.3. Company snapshot

10.1.4. Operating business segments

10.1.5. Product portfolio

10.1.6. Business performance

10.2. AngioDynamics, Inc.

10.2.1. Company overview

10.2.2. Key Executives

10.2.3. Company snapshot

10.2.4. Operating business segments

10.2.5. Product portfolio

10.2.6. Business performance

10.3. B. Braun SE

10.3.1. Company overview

10.3.2. Key Executives

10.3.3. Company snapshot

10.3.4. Operating business segments

10.3.5. Product portfolio

10.3.6. Business performance

10.4. Becton, Dickinson and Company

10.4.1. Company overview

10.4.2. Key Executives

10.4.3. Company snapshot

10.4.4. Operating business segments

10.4.5. Product portfolio

10.4.6. Business performance

10.5. ICU Medical Inc.

10.5.1. Company overview

10.5.2. Key Executives

10.5.3. Company snapshot

10.5.4. Operating business segments

10.5.5. Product portfolio

10.5.6. Business performance

10.6. Medtronic plc

10.6.1. Company overview

10.6.2. Key Executives

10.6.3. Company snapshot

10.6.4. Operating business segments

10.6.5. Product portfolio

10.6.6. Business performance

10.7. Merit Medical Systems Inc.

10.7.1. Company overview

10.7.2. Key Executives

10.7.3. Company snapshot

10.7.4. Operating business segments

10.7.5. Product portfolio

10.7.6. Business performance

10.7.7. Key strategic moves and developments

10.8. Rex Medical, LLC.

10.8.1. Company overview

10.8.2. Key Executives

10.8.3. Company snapshot

10.8.4. Operating business segments

10.8.5. Product portfolio

10.9. Teleflex Incorporated

10.9.1. Company overview

10.9.2. Key Executives

10.9.3. Company snapshot

10.9.4. Operating business segments

10.9.5. Product portfolio

10.9.6. Business performance

10.10. Vygon

10.10.1. Company overview

10.10.2. Key Executives

10.10.3. Company snapshot

10.10.4. Operating business segments

10.10.5. Product portfoli

LIST OF TABLES

TABLE 01. GLOBAL CENTRAL VENOUS CATHETER MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 02. CENTRAL VENOUS CATHETER MARKET FOR TUNNELED CATHETERS, BY REGION, 2022-2032 ($MILLION)

TABLE 03. CENTRAL VENOUS CATHETER MARKET FOR NON-TUNNELED CATHETERS, BY REGION, 2022-2032 ($MILLION)

TABLE 04. GLOBAL CENTRAL VENOUS CATHETER MARKET, BY PROPERTY, 2022-2032 ($MILLION)

TABLE 05. CENTRAL VENOUS CATHETER MARKET FOR ANTIMICROBIAL CATHETERS, BY REGION, 2022-2032 ($MILLION)

TABLE 06. CENTRAL VENOUS CATHETER MARKET FOR NON-ANTIMICROBIAL CATHETERS, BY REGION, 2022-2032 ($MILLION)

TABLE 07. GLOBAL CENTRAL VENOUS CATHETER MARKET, BY DESIGN, 2022-2032 ($MILLION)

TABLE 08. CENTRAL VENOUS CATHETER MARKET FOR SINGLE LUMEN, BY REGION, 2022-2032 ($MILLION)

TABLE 09. CENTRAL VENOUS CATHETER MARKET FOR DOUBLE LUMEN, BY REGION, 2022-2032 ($MILLION)

TABLE 10. CENTRAL VENOUS CATHETER MARKET FOR MULTIPLE LUMEN, BY REGION, 2022-2032 ($MILLION)

TABLE 11. GLOBAL CENTRAL VENOUS CATHETER MARKET, BY END-USER, 2022-2032 ($MILLION)

TABLE 12. CENTRAL VENOUS CATHETER MARKET FOR HOSPITAL, BY REGION, 2022-2032 ($MILLION)

TABLE 13. CENTRAL VENOUS CATHETER MARKET FOR CANCER TREATMENT CENTERS, BY REGION, 2022-2032 ($MILLION)

TABLE 14. CENTRAL VENOUS CATHETER MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)

TABLE 15. CENTRAL VENOUS CATHETER MARKET, BY REGION, 2022-2032 ($MILLION)

TABLE 16. NORTH AMERICA CENTRAL VENOUS CATHETER MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 17. NORTH AMERICA CENTRAL VENOUS CATHETER MARKET, BY PROPERTY, 2022-2032 ($MILLION)

TABLE 18. NORTH AMERICA CENTRAL VENOUS CATHETER MARKET, BY DESIGN, 2022-2032 ($MILLION)

TABLE 19. NORTH AMERICA CENTRAL VENOUS CATHETER MARKET, BY END-USER, 2022-2032 ($MILLION)

TABLE 20. NORTH AMERICA CENTRAL VENOUS CATHETER MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 21. U.S. CENTRAL VENOUS CATHETER MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 22. U.S. CENTRAL VENOUS CATHETER MARKET, BY PROPERTY, 2022-2032 ($MILLION)

TABLE 23. U.S. CENTRAL VENOUS CATHETER MARKET, BY DESIGN, 2022-2032 ($MILLION)

TABLE 24. U.S. CENTRAL VENOUS CATHETER MARKET, BY END-USER, 2022-2032 ($MILLION)

TABLE 25. CANADA CENTRAL VENOUS CATHETER MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 26. CANADA CENTRAL VENOUS CATHETER MARKET, BY PROPERTY, 2022-2032 ($MILLION)

TABLE 27. CANADA CENTRAL VENOUS CATHETER MARKET, BY DESIGN, 2022-2032 ($MILLION)

TABLE 28. CANADA CENTRAL VENOUS CATHETER MARKET, BY END-USER, 2022-2032 ($MILLION)

TABLE 29. MEXICO CENTRAL VENOUS CATHETER MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 30. MEXICO CENTRAL VENOUS CATHETER MARKET, BY PROPERTY, 2022-2032 ($MILLION)

TABLE 31. MEXICO CENTRAL VENOUS CATHETER MARKET, BY DESIGN, 2022-2032 ($MILLION)

TABLE 32. MEXICO CENTRAL VENOUS CATHETER MARKET, BY END-USER, 2022-2032 ($MILLION)

TABLE 33. EUROPE CENTRAL VENOUS CATHETER MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 34. EUROPE CENTRAL VENOUS CATHETER MARKET, BY PROPERTY, 2022-2032 ($MILLION)

TABLE 35. EUROPE CENTRAL VENOUS CATHETER MARKET, BY DESIGN, 2022-2032 ($MILLION)

TABLE 36. EUROPE CENTRAL VENOUS CATHETER MARKET, BY END-USER, 2022-2032 ($MILLION)

TABLE 37. EUROPE CENTRAL VENOUS CATHETER MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 38. GERMANY CENTRAL VENOUS CATHETER MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 39. GERMANY CENTRAL VENOUS CATHETER MARKET, BY PROPERTY, 2022-2032 ($MILLION)

TABLE 40. GERMANY CENTRAL VENOUS CATHETER MARKET, BY DESIGN, 2022-2032 ($MILLION)

TABLE 41. GERMANY CENTRAL VENOUS CATHETER MARKET, BY END-USER, 2022-2032 ($MILLION)

TABLE 42. FRANCE CENTRAL VENOUS CATHETER MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 43. FRANCE CENTRAL VENOUS CATHETER MARKET, BY PROPERTY, 2022-2032 ($MILLION)

TABLE 44. FRANCE CENTRAL VENOUS CATHETER MARKET, BY DESIGN, 2022-2032 ($MILLION)

TABLE 45. FRANCE CENTRAL VENOUS CATHETER MARKET, BY END-USER, 2022-2032 ($MILLION)

TABLE 46. UK CENTRAL VENOUS CATHETER MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 47. UK CENTRAL VENOUS CATHETER MARKET, BY PROPERTY, 2022-2032 ($MILLION)

TABLE 48. UK CENTRAL VENOUS CATHETER MARKET, BY DESIGN, 2022-2032 ($MILLION)

TABLE 49. UK CENTRAL VENOUS CATHETER MARKET, BY END-USER, 2022-2032 ($MILLION)

TABLE 50. ITALY CENTRAL VENOUS CATHETER MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 51. ITALY CENTRAL VENOUS CATHETER MARKET, BY PROPERTY, 2022-2032 ($MILLION)

TABLE 52. ITALY CENTRAL VENOUS CATHETER MARKET, BY DESIGN, 2022-2032 ($MILLION)

TABLE 53. ITALY CENTRAL VENOUS CATHETER MARKET, BY END-USER, 2022-2032 ($MILLION)

TABLE 54. SPAIN CENTRAL VENOUS CATHETER MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 55. SPAIN CENTRAL VENOUS CATHETER MARKET, BY PROPERTY, 2022-2032 ($MILLION)

TABLE 56. SPAIN CENTRAL VENOUS CATHETER MARKET, BY DESIGN, 2022-2032 ($MILLION)

TABLE 57. SPAIN CENTRAL VENOUS CATHETER MARKET, BY END-USER, 2022-2032 ($MILLION)

TABLE 58. REST OF EUROPE CENTRAL VENOUS CATHETER MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 59. REST OF EUROPE CENTRAL VENOUS CATHETER MARKET, BY PROPERTY, 2022-2032 ($MILLION)

TABLE 60. REST OF EUROPE CENTRAL VENOUS CATHETER MARKET, BY DESIGN, 2022-2032 ($MILLION)

TABLE 61. REST OF EUROPE CENTRAL VENOUS CATHETER MARKET, BY END-USER, 2022-2032 ($MILLION)

TABLE 62. ASIA-PACIFIC CENTRAL VENOUS CATHETER MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 63. ASIA-PACIFIC CENTRAL VENOUS CATHETER MARKET, BY PROPERTY, 2022-2032 ($MILLION)

TABLE 64. ASIA-PACIFIC CENTRAL VENOUS CATHETER MARKET, BY DESIGN, 2022-2032 ($MILLION)

TABLE 65. ASIA-PACIFIC CENTRAL VENOUS CATHETER MARKET, BY END-USER, 2022-2032 ($MILLION)

TABLE 66. ASIA-PACIFIC CENTRAL VENOUS CATHETER MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 67. CHINA CENTRAL VENOUS CATHETER MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 68. CHINA CENTRAL VENOUS CATHETER MARKET, BY PROPERTY, 2022-2032 ($MILLION)

TABLE 69. CHINA CENTRAL VENOUS CATHETER MARKET, BY DESIGN, 2022-2032 ($MILLION)

TABLE 70. CHINA CENTRAL VENOUS CATHETER MARKET, BY END-USER, 2022-2032 ($MILLION)

TABLE 71. JAPAN CENTRAL VENOUS CATHETER MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 72. JAPAN CENTRAL VENOUS CATHETER MARKET, BY PROPERTY, 2022-2032 ($MILLION)

TABLE 73. JAPAN CENTRAL VENOUS CATHETER MARKET, BY DESIGN, 2022-2032 ($MILLION)

TABLE 74. JAPAN CENTRAL VENOUS CATHETER MARKET, BY END-USER, 2022-2032 ($MILLION)

TABLE 75. INDIA CENTRAL VENOUS CATHETER MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 76. INDIA CENTRAL VENOUS CATHETER MARKET, BY PROPERTY, 2022-2032 ($MILLION)

TABLE 77. INDIA CENTRAL VENOUS CATHETER MARKET, BY DESIGN, 2022-2032 ($MILLION)

TABLE 78. INDIA CENTRAL VENOUS CATHETER MARKET, BY END-USER, 2022-2032 ($MILLION)

TABLE 79. AUSTRALIA CENTRAL VENOUS CATHETER MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 80. AUSTRALIA CENTRAL VENOUS CATHETER MARKET, BY PROPERTY, 2022-2032 ($MILLION)

TABLE 81. AUSTRALIA CENTRAL VENOUS CATHETER MARKET, BY DESIGN, 2022-2032 ($MILLION)

TABLE 82. AUSTRALIA CENTRAL VENOUS CATHETER MARKET, BY END-USER, 2022-2032 ($MILLION)

TABLE 83. SOUTH KOREA CENTRAL VENOUS CATHETER MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 84. SOUTH KOREA CENTRAL VENOUS CATHETER MARKET, BY PROPERTY, 2022-2032 ($MILLION)

TABLE 85. SOUTH KOREA CENTRAL VENOUS CATHETER MARKET, BY DESIGN, 2022-2032 ($MILLION)

TABLE 86. SOUTH KOREA CENTRAL VENOUS CATHETER MARKET, BY END-USER, 2022-2032 ($MILLION)

TABLE 87. REST OF ASIA-PACIFIC CENTRAL VENOUS CATHETER MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 88. REST OF ASIA-PACIFIC CENTRAL VENOUS CATHETER MARKET, BY PROPERTY, 2022-2032 ($MILLION)

TABLE 89. REST OF ASIA-PACIFIC CENTRAL VENOUS CATHETER MARKET, BY DESIGN, 2022-2032 ($MILLION)

TABLE 90. REST OF ASIA-PACIFIC CENTRAL VENOUS CATHETER MARKET, BY END-USER, 2022-2032 ($MILLION)

TABLE 91. LAMEA CENTRAL VENOUS CATHETER MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 92. LAMEA CENTRAL VENOUS CATHETER MARKET, BY PROPERTY, 2022-2032 ($MILLION)

TABLE 93. LAMEA CENTRAL VENOUS CATHETER MARKET, BY DESIGN, 2022-2032 ($MILLION)

TABLE 94. LAMEA CENTRAL VENOUS CATHETER MARKET, BY END-USER, 2022-2032 ($MILLION)

TABLE 95. LAMEA CENTRAL VENOUS CATHETER MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 96. BRAZIL CENTRAL VENOUS CATHETER MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 97. BRAZIL CENTRAL VENOUS CATHETER MARKET, BY PROPERTY, 2022-2032 ($MILLION)

TABLE 98. BRAZIL CENTRAL VENOUS CATHETER MARKET, BY DESIGN, 2022-2032 ($MILLION)

TABLE 99. BRAZIL CENTRAL VENOUS CATHETER MARKET, BY END-USER, 2022-2032 ($MILLION)

TABLE 100. SAUDI ARABIA CENTRAL VENOUS CATHETER MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 101. SAUDI ARABIA CENTRAL VENOUS CATHETER MARKET, BY PROPERTY, 2022-2032 ($MILLION)

TABLE 102. SAUDI ARABIA CENTRAL VENOUS CATHETER MARKET, BY DESIGN, 2022-2032 ($MILLION)

TABLE 103. SAUDI ARABIA CENTRAL VENOUS CATHETER MARKET, BY END-USER, 2022-2032 ($MILLION)

TABLE 104. SOUTH AFRICA CENTRAL VENOUS CATHETER MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 105. SOUTH AFRICA CENTRAL VENOUS CATHETER MARKET, BY PROPERTY, 2022-2032 ($MILLION)

TABLE 106. SOUTH AFRICA CENTRAL VENOUS CATHETER MARKET, BY DESIGN, 2022-2032 ($MILLION)

TABLE 107. SOUTH AFRICA CENTRAL VENOUS CATHETER MARKET, BY END-USER, 2022-2032 ($MILLION)

TABLE 108. REST OF LAMEA CENTRAL VENOUS CATHETER MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 109. REST OF LAMEA CENTRAL VENOUS CATHETER MARKET, BY PROPERTY, 2022-2032 ($MILLION)

TABLE 110. REST OF LAMEA CENTRAL VENOUS CATHETER MARKET, BY DESIGN, 2022-2032 ($MILLION)

TABLE 111. REST OF LAMEA CENTRAL VENOUS CATHETER MARKET, BY END-USER, 2022-2032 ($MILLION)

TABLE 112. ASAHI KASEI CORPORATION.: KEY EXECUTIVES

TABLE 113. ASAHI KASEI CORPORATION.: COMPANY SNAPSHOT

TABLE 114. ASAHI KASEI CORPORATION.: PRODUCT SEGMENTS

TABLE 115. ASAHI KASEI CORPORATION.: PRODUCT PORTFOLIO

TABLE 116. ANGIODYNAMICS, INC.: KEY EXECUTIVES

TABLE 117. ANGIODYNAMICS, INC.: COMPANY SNAPSHOT

TABLE 118. ANGIODYNAMICS, INC.: PRODUCT SEGMENTS

TABLE 119. ANGIODYNAMICS, INC.: PRODUCT PORTFOLIO

TABLE 120. B. BRAUN SE: KEY EXECUTIVES

TABLE 121. B. BRAUN SE: COMPANY SNAPSHOT

TABLE 122. B. BRAUN SE: PRODUCT SEGMENTS

TABLE 123. B. BRAUN SE: PRODUCT PORTFOLIO

TABLE 124. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES

TABLE 125. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT

TABLE 126. BECTON, DICKINSON AND COMPANY: PRODUCT SEGMENTS

TABLE 127. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO

TABLE 128. ICU MEDICAL INC.: KEY EXECUTIVES

TABLE 129. ICU MEDICAL INC.: COMPANY SNAPSHOT

TABLE 130. ICU MEDICAL INC.: PRODUCT SEGMENTS

TABLE 131. ICU MEDICAL INC.: PRODUCT PORTFOLIO

TABLE 132. MEDTRONIC PLC: KEY EXECUTIVES

TABLE 133. MEDTRONIC PLC: COMPANY SNAPSHOT

TABLE 134. MEDTRONIC PLC: PRODUCT SEGMENTS

TABLE 135. MEDTRONIC PLC: PRODUCT PORTFOLIO

TABLE 136. MERIT MEDICAL SYSTEMS INC.: KEY EXECUTIVES

TABLE 137. MERIT MEDICAL SYSTEMS INC.: COMPANY SNAPSHOT

TABLE 138. MERIT MEDICAL SYSTEMS INC.: PRODUCT SEGMENTS

TABLE 139. MERIT MEDICAL SYSTEMS INC.: PRODUCT PORTFOLIO

TABLE 140. MERIT MEDICAL SYSTEMS INC.: KEY STRATERGIES

TABLE 141. REX MEDICAL, LLC.: KEY EXECUTIVES

TABLE 142. REX MEDICAL, LLC.: COMPANY SNAPSHOT

TABLE 143. REX MEDICAL, LLC.: PRODUCT SEGMENTS

TABLE 144. REX MEDICAL, LLC.: PRODUCT PORTFOLIO

TABLE 145. TELEFLEX INCORPORATED: KEY EXECUTIVES

TABLE 146. TELEFLEX INCORPORATED: COMPANY SNAPSHOT

TABLE 147. TELEFLEX INCORPORATED: PRODUCT SEGMENTS

TABLE 148. TELEFLEX INCORPORATED: PRODUCT PORTFOLIO

TABLE 149. VYGON: KEY EXECUTIVES

TABLE 150. VYGON: COMPANY SNAPSHOT

TABLE 151. VYGON: PRODUCT SEGMENTS

TABLE 152. VYGON: PRODUCT PORTFOLIO LIST OF FIGURES

FIGURE 01. CENTRAL VENOUS CATHETER MARKET, 2022-2032

FIGURE 02. SEGMENTATION OF CENTRAL VENOUS CATHETER MARKET,2022-2032

FIGURE 03. TOP INVESTMENT POCKETS IN CENTRAL VENOUS CATHETER MARKET (2023-2032)

FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS

FIGURE 05. MODERATE THREAT OF NEW ENTRANTS

FIGURE 06. MODERATE THREAT OF SUBSTITUTES

FIGURE 07. MODERATE INTENSITY OF RIVALRY

FIGURE 08. MODERATE BARGAINING POWER OF BUYERS

FIGURE 09. GLOBAL CENTRAL VENOUS CATHETER MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 10. CENTRAL VENOUS CATHETER MARKET, BY PRODUCT TYPE, 2022(%)

FIGURE 11. COMPARATIVE SHARE ANALYSIS OF CENTRAL VENOUS CATHETER MARKET FOR TUNNELED CATHETERS, BY COUNTRY 2022 AND 2032(%)

FIGURE 12. COMPARATIVE SHARE ANALYSIS OF CENTRAL VENOUS CATHETER MARKET FOR NON-TUNNELED CATHETERS, BY COUNTRY 2022 AND 2032(%)

FIGURE 13. CENTRAL VENOUS CATHETER MARKET, BY PROPERTY, 2022(%)

FIGURE 14. COMPARATIVE SHARE ANALYSIS OF CENTRAL VENOUS CATHETER MARKET FOR ANTIMICROBIAL CATHETERS, BY COUNTRY 2022 AND 2032(%)

FIGURE 15. COMPARATIVE SHARE ANALYSIS OF CENTRAL VENOUS CATHETER MARKET FOR NON-ANTIMICROBIAL CATHETERS, BY COUNTRY 2022 AND 2032(%)

FIGURE 16. CENTRAL VENOUS CATHETER MARKET, BY DESIGN, 2022(%)

FIGURE 17. COMPARATIVE SHARE ANALYSIS OF CENTRAL VENOUS CATHETER MARKET FOR SINGLE LUMEN, BY COUNTRY 2022 AND 2032(%)

FIGURE 18. COMPARATIVE SHARE ANALYSIS OF CENTRAL VENOUS CATHETER MARKET FOR DOUBLE LUMEN, BY COUNTRY 2022 AND 2032(%)

FIGURE 19. COMPARATIVE SHARE ANALYSIS OF CENTRAL VENOUS CATHETER MARKET FOR MULTIPLE LUMEN, BY COUNTRY 2022 AND 2032(%)

FIGURE 20. CENTRAL VENOUS CATHETER MARKET, BY END-USER, 2022(%)

FIGURE 21. COMPARATIVE SHARE ANALYSIS OF CENTRAL VENOUS CATHETER MARKET FOR HOSPITAL, BY COUNTRY 2022 AND 2032(%)

FIGURE 22. COMPARATIVE SHARE ANALYSIS OF CENTRAL VENOUS CATHETER MARKET FOR CANCER TREATMENT CENTERS, BY COUNTRY 2022 AND 2032(%)

FIGURE 23. COMPARATIVE SHARE ANALYSIS OF CENTRAL VENOUS CATHETER MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)

FIGURE 24. CENTRAL VENOUS CATHETER MARKET BY REGION, 2022(%)

FIGURE 25. U.S. CENTRAL VENOUS CATHETER MARKET, 2022-2032 ($MILLION)

FIGURE 26. CANADA CENTRAL VENOUS CATHETER MARKET, 2022-2032 ($MILLION)

FIGURE 27. MEXICO CENTRAL VENOUS CATHETER MARKET, 2022-2032 ($MILLION)

FIGURE 28. GERMANY CENTRAL VENOUS CATHETER MARKET, 2022-2032 ($MILLION)

FIGURE 29. FRANCE CENTRAL VENOUS CATHETER MARKET, 2022-2032 ($MILLION)

FIGURE 30. UK CENTRAL VENOUS CATHETER MARKET, 2022-2032 ($MILLION)

FIGURE 31. ITALY CENTRAL VENOUS CATHETER MARKET, 2022-2032 ($MILLION)

FIGURE 32. SPAIN CENTRAL VENOUS CATHETER MARKET, 2022-2032 ($MILLION)

FIGURE 33. REST OF EUROPE CENTRAL VENOUS CATHETER MARKET, 2022-2032 ($MILLION)

FIGURE 34. CHINA CENTRAL VENOUS CATHETER MARKET, 2022-2032 ($MILLION)

FIGURE 35. JAPAN CENTRAL VENOUS CATHETER MARKET, 2022-2032 ($MILLION)

FIGURE 36. INDIA CENTRAL VENOUS CATHETER MARKET, 2022-2032 ($MILLION)

FIGURE 37. AUSTRALIA CENTRAL VENOUS CATHETER MARKET, 2022-2032 ($MILLION)

FIGURE 38. SOUTH KOREA CENTRAL VENOUS CATHETER MARKET, 2022-2032 ($MILLION)

FIGURE 39. REST OF ASIA-PACIFIC CENTRAL VENOUS CATHETER MARKET, 2022-2032 ($MILLION)

FIGURE 40. BRAZIL CENTRAL VENOUS CATHETER MARKET, 2022-2032 ($MILLION)

FIGURE 41. SAUDI ARABIA CENTRAL VENOUS CATHETER MARKET, 2022-2032 ($MILLION)

FIGURE 42. SOUTH AFRICA CENTRAL VENOUS CATHETER MARKET, 2022-2032 ($MILLION)

FIGURE 43. REST OF LAMEA CENTRAL VENOUS CATHETER MARKET, 2022-2032 ($MILLION)

FIGURE 44. TOP WINNING STRATEGIES, BY YEAR

FIGURE 45. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 46. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 47. PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 48. COMPETITIVE DASHBOARD

FIGURE 49. COMPETITIVE HEATMAP: CENTRAL VENOUS CATHETER MARKET

FIGURE 50. TOP PLAYER POSITIONING, 2022

FIGURE 51. ASAHI KASEI CORPORATION: NET SALES, 2020-2022 ($MILLION)

FIGURE 52. ASAHI KASEI CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 53. ASAHI KASEI CORPORATION: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 54. ANGIODYNAMICS, INC.: NET SALES, 2020-2022 ($MILLION)

FIGURE 55. ANGIODYNAMICS, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 56. ANGIODYNAMICS, INC.: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 57. B. BRAUN SE: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 58. B. BRAUN SE: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 59. B. BRAUN SE: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 60. BECTON, DICKINSON AND COMPANY: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 61. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 62. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 63. ICU MEDICAL INC.: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 64. ICU MEDICAL INC.: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 65. ICU MEDICAL INC.: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 66. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)

FIGURE 67. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 68. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 69. MERIT MEDICAL SYSTEMS INC.: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 70. MERIT MEDICAL SYSTEMS INC.: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 71. MERIT MEDICAL SYSTEMS INC.: REVENUE SHARE BY REGION, 2021 (%